MVA newsletter no 5, May 2004

 

: NEWS INDEX

 

• MVA Business Academy: How to collaborate with the board
• MVA Drug Development Network: The first formulated trial product - quick fix or strategic decision?
• New job opportunities for unemployed scientists within biotech and medicine
• MVA's Managing Director is appointed Director of Lund University Hospital 
• MVA CV database - find your next employee here
• New head of clinical development transfers from Maxygen, Denmark to Biovent, Sweden
• Top ranking for Trial Form Support in growth ranking list 2004
• Erysave signs an exclusive alliance with ATS Medical, Inc. in cardiac surgery
• Pfizer to expand in Helsingborg
• US National Cancer Institute and TopoTarget in collaboration

 

: MVA NEWS

 

MVA Business Academy: How to collaborate with the board

26 May 2004 / Øresundshuset / Copenhagen

 

Lecturer: CEO Kirsten Drejer, Symphogen.

Symphogen was founded in 2000 and employs 40 people. Symphogen has a strong international profile, including US venture capital from Essex Woodlands Health Ventures and board members from USA and UK. CEO Kirsten Drejer will introduce how she utilizes the competencies of the board members in the way to optimize the performance of the company.
More information... (in English) www.mva.org/businessacademy

 

 

 

MVA Drug Development Network / 27 May 2004

The first formulated trial product - quick fix or strategic decision?

Bengt Westrin, Vice President from Camurus AB, will give a presentation on the importance of drug formulation in relation to clinical trial outcomes.

More information... (in English) www.mva.org/composite-1021.htm

 

MVA press release / 24 May

New job opportunities for unemployed scientists within biotech and medicine.

More information... (in Swedish) www.mva.org/composite-1040.htm

 

MVA press release / 4 May

Bent Christensen, Medicon Valley Academy's Managing Director is appointed Director of Lund University Hospital.

More information... (in Danish) www.mva.org/composite-1025.htm

 

 

: MEDICON VALLEY NEWS

 

New head of clinical development transfers from Maxygen, Denmark to Biovent, Sweden

Lund based drug development company, BioInvent, has appointed Steven Glazer as their new Vice President and Head of Clinical Affairs.

More information... (in English) www.mva.org/composite-1039.htm

 

Top ranking for Trial Form Support in growth ranking list 2004

Trial Form Support (TFS), who work with clinical contract research, has grown rapidly according to a new ranking list produced by growth consultant company Ahrens and the Swedish newspaper Svenska Dagbladet.

More information... (in English) www.mva.org/composite-1038.htm

 

ErySave signs an exclusive alliance with ATS Medical, Inc. in cardiac surgery

ErySave has signed an exclusive agreement granting ATS Medical worldwide rights for ErySaves PARSUS filtration technology for cardiac surgery.

More information... (in English) www.mva.org/composite-1036.htm

 

Pfizer to expand in Helsingborg

U.S. pharmaceutical giant Pfizer has announced plans to expand its Swedish business. Pfizer will cement the city of Helsingborg in Skåne as its global center for production and distribution of Nicorette products.

More information... (in English) www.mva.org/composite-1035.htm

 

US National Cancer Institute and TopoTarget in Collaboration

The US National Cancer Institute (NCI) and TopoTarget A/S, the oncology-focused biopharmaceutical company based in Denmark and the UK, are to collaborate to combat solid and hematological malignancies.

More information... (in English) www.mva.org/composite-1027.htm

 

 

: EVENTS

 

Intellectual Property Rights in the Biotech Industry

15 June 2004 / Radisson SAS Scandinavia Hotel / Copenhagen / Denmark

This international conference will examine the role of freedom to operate in order to create value from biotech inventions throughout the entire patent life cycle. The world’s leading expertise in the patent field will be present, from organisations such as Serono, Aventis, Novo Nordisk, Amersham Biosciences and the European Patent Office amongst others. This event provides you with a platform to design a successful IPR strategy with lessons learnt from the pioneers in the patent field.

More information... (in English) www.mva.org/composite-1026.htm

 

26th World Congress of the International Federation of Biomedical Science

13-18 June 2004 / Stockholm International Fairs / Sweden

International Federation of Biomedical Laboratory Science will hold its 26th Congress in Stockholm, Sweden. The theme for the congress is Public Health and Biomedical Laboratory Science which will highlight the significant role played by biomedical scientists in health and medical care. The theme will comprise research, development and practical application in the laboratory.

More information... (in English) www.mva.org/composite-944.htm

 

7th Biotech & Finance Forum

21-23 June 2004 / Munich / Germany

The Biotech & Finance Forum is a European event focused on private biotech companies. An initiative of the European Commission, the BFF is organised by Europe Unlimited and run in association with EuropaBio.

Special benefits for members